Mesenchymal Stem Cell Identification via Molecular Markers
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for regenerative medicine using mesenchymal stem cells are hindered by the inability to accurately and easily distinguish these cells from other connective tissue cells like fibroblasts, osteoblasts, and chondrocytes, which is crucial for maintaining their pluripotency and ensuring their effective application in tissue regeneration.
Innovation Solution
A method utilizing specific gene markers, identified through expression profiling, to differentiate mesenchymal stem cells from connective tissue cells by detecting unique gene expression patterns, allowing for precise identification and separation using DNA microarrays and antibodies.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional cell collection and culturing methods are used, then mesenchymal stem cells can be obtained and multiplied, but the cells cannot be accurately distinguished from other connective tissue cells like fibroblasts, osteoblasts, and chondrocytes
Solution Approach 1:
The patent changes the identification parameter from morphological characteristics to molecular marker expression patterns. By detecting specific gene expression profiles (such as CD73, CD90, CD105, CD146, STC1, and PDGFRα), the method achieves accurate distinction between mesenchymal stem cells and other connective tissue cells, resolving the contradiction between identification accuracy and method complexity.
Solution Approach 2:
The patent replaces mechanical/morphological identification methods with molecular detection techniques. Instead of relying on visual or physical characteristics that are difficult to distinguish, the method uses molecular markers detected through biochemical assays, enabling precise cell type identification without complex mechanical separation systems.
2Productivity
If mesenchymal stem cells are cultured without differentiation, then cell multiplication is achieved, but the cells may lose their pluripotency and become indistinguishable from other connective tissue cells
Solution Approach 1:
The patent implements a feedback mechanism where cell identity is continuously monitored through molecular marker detection during culture. By detecting the expression levels of stem cell markers (CD73, CD90, CD105, etc.), the method provides feedback to ensure cells maintain their pluripotent state, allowing high multiplication rates while preserving reliability through continuous identity verification.
3Measurement precision
If molecular markers are used to distinguish cell types, then identification accuracy is improved, but the complexity of detection methods increases
Solution Approach 1:
The patent identifies a set of universal molecular markers (CD73, CD90, CD105, CD146, STC1, PDGFRα) that can be detected using standard biochemical techniques. These markers serve multiple functions: they identify mesenchymal stem cell type, maintain pluripotency assessment, and enable differentiation potential evaluation, thereby achieving high measurement precision without proportionally increasing detection difficulty.
Data Source
AI summary
Disclosed is a method for distinguishing a mesenchymal stem cell comprising, using at least one gene selected from the genes having the nucleotide sequences indicated by the accession numbers shown in Table 1 as a distinguish marker, detecting the difference in expression of the distinguish marker between a mesenchymal stem cell and a connective tissue cell to distinguish the mesenchymal stem cell from the connective tissue cell. This method enables to distinguish an undifferentiated mesenchymal stem cell from other connective tissue cell such as fibroblasts, osteoblasts, chondrocytes and adipose cells with good accuracy. A mesenchymal stem cell given by this method or a composition comprising the mesenchymal stem sell can be used as a therapeutic for use in the regenerative medicine.